Bannerbild German Brest Group - Forschung

Forschungsprojekte der German Breast Group

Translationale Forschung

Um mehr über die Ursachen und den Verlauf von Brustkrebserkankungen zu erfahren, hat die German Breast Group ein Subboard für translationale Forschung eingerichtet. Die Mitglieder forschen an der Schnittstelle zwischen klinischer und experimenteller Wissenschaft. Das Ziel sind individuellere Therapien für Patientinnen.

Translationale Forschung


The goal of EURECA (Enabling information re-Use by linking clinical REsearch and Care) is to enable seamless, secure, scalable and consistent linkage of healthcare information residing in electronic health record (EHR) systems with information in clinical research information systems, such as clinical trials.


RESPONSIFY intends to prove the hypothesis that a predictive biomarker approach will be able to distinguish responders from non-responders and will therefore spare patients from unnecessary toxicities. This will help to significantly reduce costs in the European healthcare system and improve prognosis and quality of life for women diagnosed with breast cancer. Using new genome-wide based techniques, we will select and validate candidate biomarkers which have the potential to predict response to therapy and affect clinical outcome.

GBG Forschungs GmbH
Martin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd